ORIGINAL RESEARCH article

Front. Psychiatry

Sec. Psychopathology

Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1509093

This article is part of the Research TopicExploring the Role of the Glymphatic System in Psychiatric DisordersView all articles

Human Immunodeficiency Virus Accelerates brain aging and disrupts the Trajectory of Glymphatic Clearance in Aging Brain

Provisionally accepted
  • 1Wenzhou Medical University, Wenzhou, China
  • 2Department of Radiology, Beijing Youan Hospital, Capital Medical University, Beijing, China
  • 3Tianjin University of Technology and Education, Tianjin, China
  • 4University of Science and Technology of China, Hefei, Anhui Province, China
  • 5Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P.R. China, WENZHOU, China

The final, formatted version of the article will be published soon.

Existing evidence indicates that HIV enters the nervous system in the early days of infection. However, the involvement of HIV in the pathogenesis of key biological aspects of the brain, such as glymphatic clearance and brain aging, and its role in explaining complex phenomena like motoric and executive dysfunction, remains unrecognized. Herein, we recruited 145 subjects to study the brain aging using brain-predicted age differences (brain-PADs) and investigate how HIV affects the typical trajectory of glymphatic clearance in aging brain. The assessment of glymphatic clearance in the aging brain was performed using a technique called "diffusion tensor image analysis along the perivascular space" (DTI-ALPS). We further evaluated the association between accelerated brain aging trajectories and cognitive performance to explain impairments observed in motor and executive functions in people living with HIV. Our results showed that subjects with HIV had increased brain-PAD in several brain structures compared to those who were HIV-negative, suggesting underlying neuropathology associated with HIV. The brain structures demonstrating accelerated aging (increased brain-PAD) include the middle frontal gyrus, pre-and post-central gyri, supramarginal gyrus, precuneus, cuneus, parietal lobule and operculum, and superior and middle occipital gyri of the left hemisphere. While normal subjects maintained typical trajectories of glymphatic clearance (as measured by the DTI-ALPS index) with age or brain-PADs for several structures, including the left central operculum, left frontal operculum, left opercular inferior frontal gyrus, and left triangular inferior frontal gyrus, none of these trajectories were maintained in subjects with HIV.Our data also show that increased brain-PAD in brain regions was associated with lower performance in motor and executive functions. These findings suggest that HIV infection accelerates brain aging and disrupts the trajectory of glymphatic clearance in aging brain, which may explain the complex mechanisms underlying cognitive impairment in motor and executive domains often seen in HIV patients. These new insights may shift our understanding of HIV pathology and aid the development of new therapeutic targets, contrary to previous approaches.

Keywords: HIV-infection, chronic inflammation, Accelarated Brain Aging, brainpredicted age difference, Glymphatic clearance trajectory, DTI-ALPS index, Motoric and Executive Dysfunction

Received: 10 Oct 2024; Accepted: 21 Apr 2025.

Copyright: © 2025 Lu, NGUCHU, Zhao, Han, Jin, Wang, Li and Shaw. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Hongjun Li, Department of Radiology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China
Peter Shaw, Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Medical University, Wenzhou, Zhejiang, 325000, P.R. China, WENZHOU, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.